Comparison of triglyceride-glucose index and HOMA-IR as indicators of insulin resistance in obese women with subclinical hypothyroidism

• Authors: Cem Onur Kirac , Vehbi Sirikci , Huseyin Avni Findikli

Abstracts

EN

Introduction and aim. Thyroid hormones play an important role in glucose metabolism as in many metabolic events. The aim of our study is to evaluate the relationship between subclinical hypothyroidism (SCH) and insulin resistance, especially in obese women. Material and methods. Newly diagnosed SCH patients with body mass index (BMI) ≥30 who applied to our outpatient clinic between March 2021 and October 2021, and euthyroid obese women who applied for routine control were included in the study. In this study, we used homeostasis model assessment of insulin resistance (HOMA-IR) and triglyceride glucose (TyG) indexes, which are noninvasive, simple and useful methods for evaluating insulin sensitivity. Results. The study included 78 female patients between the ages of 19 and 64. A correlational analysis was performed between thyroid stimulating hormone (TSH) and HOMA-IR, TyG, and BMI. The results showed that TSH levels were positively correlated with HOMA-IR (R=0.297, p=0.008), TyG (R=0.316, p=0.005) and BMI (R=0.307, p=0.006). This relationship was stronger for TyG compared to the other variables. As another finding, BMI was positively correlated with HOMA-IR (R=0.359, p=0.001) and TyG (R=0.404, p<0.001). This relationship was stronger for TyG than HOMA-IR. Conclusion. These results show that patients with SCH are at risk of developing diseases that accompany insulin resistance, such as metabolic syndrome and cardiovascular disorders. The most important finding of our study is that the TyG index gives more significant results than HOMA-IR, especially in obese women.

Keywords

EN

HOMA-IR; insulin resistance; subclinical hypothyroidism; triglyceride-glucose index

• Publisher: Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
• Journal: European Journal of Clinical and Experimental Medicine
• Year: 2022
• Issue: 4
• Pages: 412-416

Dates

published

2022

Contributors

author

Cem Onur Kirac

• Department of Internal Medicine, Division of Endocrinology and Metabolism, Necip Fazil City Hospital, Kahramanmaras, Turkey

author

Vehbi Sirikci

• Department of Internal Medicine, Necip Fazil City Hospital, Kahramanmaras, Turkey

author

Huseyin Avni Findikli

• Department of Internal Medicine, Necip Fazil City Hospital, Kahramanmaras, Turkey

Identifiers

DOI

10.15584/ejcem.2022.4.5

Biblioteka Nauki

2216805